{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T09:08:06Z","timestamp":1791623286583,"version":"4.3.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T00:00:00Z","timestamp":1768089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-09524-y","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T23:23:51Z","timestamp":1768087431000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Nimbolide ameliorates ARDS and ulcerative colitis by disrupting NLRP3 inflammasome activation"],"prefix":"10.1038","volume":"9","author":[{"given":"Haowen","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiying","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8547-0014","authenticated-orcid":false,"given":"Yongan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4709-066X","authenticated-orcid":false,"given":"Zhaocai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,11]]},"reference":[{"key":"9524_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41577-024-01075-9","volume":"25","author":"RC Coll","year":"2025","unstructured":"Coll, R. C. & Schroder, K. Inflammasome components as new therapeutic targets in inflammatory disease. Nat. Rev. Immunol. 25, 22\u201341 (2025).","journal-title":"Nat. Rev. Immunol."},{"key":"9524_CR2","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1146\/annurev-immunol-081022-021207","volume":"41","author":"J Fu","year":"2023","unstructured":"Fu, J. & Wu, H. Structural Mechanisms of NLRP3 Inflammasome Assembly and Activation. Annu Rev. Immunol. 41, 301\u2013316 (2023).","journal-title":"Annu Rev. Immunol."},{"key":"9524_CR3","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","volume":"18","author":"Y Huang","year":"2021","unstructured":"Huang, Y., Xu, W. & Zhou, R. NLRP3 inflammasome activation and cell death. Cell Mol. Immunol. 18, 2114\u20132127 (2021).","journal-title":"Cell Mol. Immunol."},{"key":"9524_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1413-8","volume":"10","author":"Y Yang","year":"2019","unstructured":"Yang, Y., Wang, H., Kouadir, M., Song, H. & Shi, F. Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors. Cell Death Dis. 10, 128 (2019).","journal-title":"Cell Death Dis."},{"key":"9524_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s12272-021-01307-9","volume":"44","author":"JK Seok","year":"2021","unstructured":"Seok, J. K., Kang, H. C., Cho, Y. Y., Lee, H. S. & Lee, J. Y. Therapeutic regulation of the NLRP3 inflammasome in chronic inflammatory diseases. Arch. Pharm. Res. 44, 16\u201335 (2021).","journal-title":"Arch. Pharm. Res"},{"key":"9524_CR6","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrd.2018.97","volume":"17","author":"MSJ Mangan","year":"2018","unstructured":"Mangan, M. S. J. et al. Targeting the NLRP3 inflammasome in inflammatory diseases. Nat. Rev. Drug Discov. 17, 588\u2013606 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"9524_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41574-024-01047-y","volume":"21","author":"M Sot\u00e1k","year":"2025","unstructured":"Sot\u00e1k, M., Clark, M., Suur, B. E. & B\u00f6rgeson, E. Inflammation and resolution in obesity. Nat. Rev. Endocrinol. 21, 45\u201361 (2025).","journal-title":"Nat. Rev. Endocrinol."},{"key":"9524_CR8","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.2337\/db23-0264","volume":"72","author":"Y Deng","year":"2023","unstructured":"Deng, Y. et al. Obesity Enables NLRP3 Activation and Induces Myocardial Fibrosis via Hyperacetylation of HADHa. Diabetes 72, 1597\u20131608 (2023).","journal-title":"Diabetes"},{"key":"9524_CR9","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.immuni.2025.01.007","volume":"58","author":"RM McManus","year":"2025","unstructured":"McManus, R. M. et al. NLRP3-mediated glutaminolysis controls microglial phagocytosis to promote Alzheimer\u2019s disease progression. Immunity 58, 326\u2013343 (2025).","journal-title":"Immunity"},{"key":"9524_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2020.100889","volume":"76","author":"L Wang","year":"2020","unstructured":"Wang, L. & Hauenstein, A. V. The NLRP3 inflammasome: Mechanism of action, role in disease and therapies. Mol. Asp. Med 76, 100889 (2020).","journal-title":"Mol. Asp. Med"},{"key":"9524_CR11","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/s41401-024-01434-1","volume":"46","author":"L-j Yan","year":"2025","unstructured":"Yan, L. -j et al. Hypocrellin A from an ethnic medicinal fungus protects against NLRP3-driven gout in mice by suppressing inflammasome activation. Acta Pharmacologica Sin. 46, 1016\u20131029 (2025).","journal-title":"Acta Pharmacologica Sin."},{"key":"9524_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.phrs.2019.01.035","volume":"142","author":"R Ward","year":"2019","unstructured":"Ward, R. et al. NLRP3 inflammasome inhibition with MCC950 improves diabetes-mediated cognitive impairment and vasoneuronal remodeling after ischemia. Pharm. Res. 142, 237\u2013250 (2019).","journal-title":"Pharm. Res"},{"key":"9524_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.117887","volume":"325","author":"L Jia","year":"2024","unstructured":"Jia, L. et al. Ginkgolide C inhibits ROS-mediated activation of NLRP3 inflammasome in chondrocytes to ameliorate osteoarthritis. J. Ethnopharmacol. 325, 117887 (2024).","journal-title":"J. Ethnopharmacol."},{"key":"9524_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118145","volume":"329","author":"X Shan","year":"2024","unstructured":"Shan, X. et al. Kai-Xin-San ameliorates Alzheimer\u2019s disease-related neuropathology and cognitive impairment in APP\/PS1 mice via the mitochondrial autophagy-NLRP3 inflammasome pathway. J. Ethnopharmacol. 329, 118145 (2024).","journal-title":"J. Ethnopharmacol."},{"key":"9524_CR15","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm.3806","volume":"21","author":"RC Coll","year":"2015","unstructured":"Coll, R. C. et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat. Med. 21, 248\u2013255 (2015).","journal-title":"Nat. Med."},{"key":"9524_CR16","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41589-019-0278-6","volume":"15","author":"A Tapia-Abell\u00e1n","year":"2019","unstructured":"Tapia-Abell\u00e1n, A. et al. MCC950 closes the active conformation of NLRP3 to an inactive state. Nat. Chem. Biol. 15, 560\u2013564 (2019).","journal-title":"Nat. Chem. Biol."},{"key":"9524_CR17","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1084\/jem.20171419","volume":"214","author":"H Jiang","year":"2017","unstructured":"Jiang, H. et al. Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders. J. Exp. Med 214, 3219\u20133238 (2017).","journal-title":"J. Exp. Med"},{"key":"9524_CR18","doi-asserted-by":"publisher","first-page":"E1530","DOI":"10.1073\/pnas.1716095115","volume":"115","author":"C Marchetti","year":"2018","unstructured":"Marchetti, C. et al. OLT1177, a \u03b2-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation. Proc. Natl. Acad. Sci. USA 115, E1530\u2013E1539 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9524_CR19","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.chembiol.2025.08.006","volume":"32","author":"W Kim","year":"2025","unstructured":"Kim, W. et al. A potent NLRP3 inhibitor effective against both MCC950-sensitive and -resistant inflammation. Cell Chem. Biol. 32, 1125\u20131139 (2025).","journal-title":"Cell Chem. Biol."},{"key":"9524_CR20","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","volume":"20","author":"AG Atanasov","year":"2021","unstructured":"Atanasov, A. G., Zotchev, S. B., Dirsch, V. M. & Supuran, C. T. Natural products in drug discovery: advances and opportunities. Nat. Rev. Drug Discov. 20, 200\u2013216 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"9524_CR21","doi-asserted-by":"publisher","first-page":"709","DOI":"10.5650\/jos.ess21389","volume":"71","author":"L Zhang","year":"2022","unstructured":"Zhang, L., Li, Y., Sun, D. & Bai, F. Protective Effect of Nimbolide against High Fat Diet-induced Obesity in Rats via Nrf2\/HO-1 Pathway. J. Oleo Sci. 71, 709\u2013720 (2022).","journal-title":"J. Oleo Sci."},{"key":"9524_CR22","doi-asserted-by":"publisher","DOI":"10.1590\/acb402125","volume":"40","author":"Y Gu","year":"2025","unstructured":"Gu, Y., Liu, B., Xia, X., Luo, C. & Ren, Y. Chemoprotective effect of nimbolide against N-methyl-N-nitrosourea induced gastric cancer via alteration of apoptosis and NF-\u03baB signaling pathway. Acta Cir. Bras. 40, e402125 (2025).","journal-title":"Acta Cir. Bras."},{"key":"9524_CR23","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1002\/ptr.7672","volume":"37","author":"M Israr","year":"2023","unstructured":"Israr, M. et al. Nimbolide attenuates complete Freund\u2019s adjuvant induced arthritis through expression regulation of toll-like receptors signaling pathway. Phytother. Res 37, 903\u2013912 (2023).","journal-title":"Phytother. Res"},{"key":"9524_CR24","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature15514","volume":"526","author":"J Shi","year":"2015","unstructured":"Shi, J. et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526, 660\u2013665 (2015).","journal-title":"Nature"},{"key":"9524_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.immuni.2017.06.020","volume":"47","author":"F Di Virgilio","year":"2017","unstructured":"Di Virgilio, F., Dal Ben, D., Sarti, A. C., Giuliani, A. L. & Falzoni, S. The P2X7 Receptor in Infection and Inflammation. Immunity 47, 15\u201331 (2017).","journal-title":"Immunity"},{"key":"9524_CR26","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/ni.1631","volume":"9","author":"V Hornung","year":"2008","unstructured":"Hornung, V. et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 9, 847\u2013856 (2008).","journal-title":"Nat. Immunol."},{"key":"9524_CR27","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/ni.1980","volume":"12","author":"K Nakahira","year":"2011","unstructured":"Nakahira, K. et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 12, 222\u2013230 (2011).","journal-title":"Nat. Immunol."},{"key":"9524_CR28","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/nature16959","volume":"530","author":"Y He","year":"2016","unstructured":"He, Y., Zeng, M. Y., Yang, D., Motro, B. & N\u00fa\u00f1ez, G. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature 530, 354\u2013357 (2016).","journal-title":"Nature"},{"key":"9524_CR29","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41586-022-04467-w","volume":"604","author":"IV Hochheiser","year":"2022","unstructured":"Hochheiser, I. V. et al. Structure of the NLRP3 decamer bound to the cytokine release inhibitor CRID3. Nature 604, 184\u2013189 (2022).","journal-title":"Nature"},{"key":"9524_CR30","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41586-022-05570-8","volume":"613","author":"L Xiao","year":"2023","unstructured":"Xiao, L., Magupalli, V. G. & Wu, H. Cryo-EM structures of the active NLRP3 inflammasome disc. Nature 613, 595\u2013600 (2023).","journal-title":"Nature"},{"key":"9524_CR31","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/s41590-025-02088-9","volume":"26","author":"S Feng","year":"2025","unstructured":"Feng, S. et al. Mechanisms of NLRP3 activation and inhibition elucidated by functional analysis of disease-associated variants. Nat. Immunol. 26, 511\u2013523 (2025).","journal-title":"Nat. Immunol."},{"key":"9524_CR32","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s42003-025-07462-9","volume":"8","author":"L Gu","year":"2025","unstructured":"Gu, L. et al. NLRP3 promotes inflammatory signaling and IL-1\u03b2 cleavage in acute lung injury caused by cell wall extract of Lactobacillus casei. Commun. Biol. 8, 20 (2025).","journal-title":"Commun. Biol."},{"key":"9524_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1265825","volume":"14","author":"JC Xue","year":"2023","unstructured":"Xue, J. C. et al. Natural products modulate NLRP3 in ulcerative colitis. Front Pharm. 14, 1265825 (2023).","journal-title":"Front Pharm."},{"key":"9524_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118928","volume":"337","author":"J Zhou","year":"2025","unstructured":"Zhou, J., Yang, Q., Wei, W., Huo, J. & Wang, W. Codonopsis pilosula polysaccharide alleviates ulcerative colitis by modulating gut microbiota and SCFA\/GPR\/NLRP3 pathway. J. Ethnopharmacol. 337, 118928 (2025).","journal-title":"J. Ethnopharmacol."},{"key":"9524_CR35","doi-asserted-by":"publisher","unstructured":"Wang, Z. et al. Polypharmacology of ambroxol in the treatment of COVID-19. Biosci. Rep. 43, https:\/\/doi.org\/10.1042\/bsr20221927 (2023).","DOI":"10.1042\/bsr20221927"},{"key":"9524_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116127","volume":"223","author":"M Shi","year":"2024","unstructured":"Shi, M. et al. Identification of 18\u03b2-glycyrrhetinic acid as an AGT inhibitor against LPS-induced myocardial dysfunction via high throughput screening. Biochem Pharm. 223, 116127 (2024).","journal-title":"Biochem Pharm."},{"key":"9524_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104887","volume":"159","author":"Y Xu","year":"2020","unstructured":"Xu, Y. et al. Sirt3 is a novel target to treat sepsis induced myocardial dysfunction by acetylated modulation of critical enzymes within cardiac tricarboxylic acid cycle. Pharm. Res 159, 104887 (2020).","journal-title":"Pharm. Res"},{"key":"9524_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118709","volume":"335","author":"W Xu","year":"2024","unstructured":"Xu, W. et al. Eurycomanone inhibits osteosarcoma growth and metastasis by suppressing GRP78 expression. J. Ethnopharmacol. 335, 118709 (2024).","journal-title":"J. Ethnopharmacol."},{"key":"9524_CR39","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1080\/14786419.2022.2119387","volume":"37","author":"MM Okba","year":"2023","unstructured":"Okba, M. M., Ezzat, M. I., Shehabeldine, A. M. & Ezzat, S. M. Eurycomanol and eurycomanone as potent inducers for cell-cycle arrest and apoptosis in small and large human lung cancer cell lines. Nat. Prod. Res. 37, 1856\u20131862 (2023).","journal-title":"Nat. Prod. Res"},{"key":"9524_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ddtec.2017.10.004","volume":"24","author":"J Bosch","year":"2017","unstructured":"Bosch, J. PPI inhibitor and stabilizer development in human diseases. Drug Discov. Today Technol. 24, 3\u20139 (2017).","journal-title":"Drug Discov. Today Technol."},{"key":"9524_CR41","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S2213-2600(19)30417-5","volume":"8","author":"J Villar","year":"2020","unstructured":"Villar, J. et al. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir. Med 8, 267\u2013276 (2020).","journal-title":"Lancet Respir. Med"},{"key":"9524_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04947-6","volume":"9","author":"H He","year":"2018","unstructured":"He, H. et al. Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity. Nat. Commun. 9, 2550 (2018).","journal-title":"Nat. Commun."},{"key":"9524_CR43","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41392-020-0186-y","volume":"5","author":"X Chen","year":"2020","unstructured":"Chen, X. et al. Target identification of natural medicine with chemical proteomics approach: probe synthesis, target fishing and protein identification. Signal Transduct. Target Ther. 5, 72 (2020).","journal-title":"Signal Transduct. Target Ther."},{"key":"9524_CR44","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.3389\/fimmu.2019.02538","volume":"10","author":"A Zahid","year":"2019","unstructured":"Zahid, A., Li, B., Kombe, A. J. K., Jin, T. & Tao, J. Pharmacological Inhibitors of the NLRP3 Inflammasome. Front Immunol. 10, 2538 (2019).","journal-title":"Front Immunol."},{"key":"9524_CR45","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.3390\/cancers17183013","volume":"17","author":"A Sharmila","year":"2025","unstructured":"Sharmila, A. et al. Nanoformulated Terpenoids in Cancer: A Review of Therapeutic Applications, Mechanisms, and Challenges. Cancers (Basel) 17, 3013 (2025).","journal-title":"Cancers (Basel)"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09524-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09524-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09524-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T15:03:14Z","timestamp":1770994994000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09524-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,11]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9524"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-09524-y","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,11]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"246"}}